Since its launch in the UK and several other European countries it has reflected positive weight loss results. Regardless, of this fact the FDA (Food Drug Administration) has still stalled the approval of Acomplia diet drug. Sanofi-Aventis, drug maker of Acomplia (Rimonabant) contemplates to launch this weight loss drug after its FDA approval under the brand name “Zimulti”.
Acomplia can be simply understood as a weight loss medication with Rimonabant as its active ingredient. Rimonabant is an effectual appetite suppressant which was unearthed and developed by a French drug maker, Sanofi- Aventis. The working of Acomplia (Rimonabant) depends upon suppressing the hunger receptors which are responsible for food consumption of the body. This means that use of Acomplia diet pill facilitates to reduce your normal appetite, thereby you would eat in small portions. Acomplia medication when accompanied with proper diet and regular workout regime results in effectual weight loss.
In accordance to studies, 20mg Acomplia diet pill is the suitable dosage which should be consumed with a glassful of water. On no account, over dosage of Acomplia is recommended even to compensate a skipped dosage.
Usage of Acomplia pill is primarily meant for obese, who have BMI (Body Mass Index)30; or even over weight individuals who have a BMI(Body Mass Index) 27 with health related risk factors.
Buy Acomplia for Europe only € 142.55
Buy Acomlia for USA only $245.00
Women planning pregnancy, pregnant women, breast-feeding mothers, heart patients, and diabetics should keep avoid usage of Acomplia diet pill. Acomplia is an oral prescription medication, thereby requires a doctor’s prescription. Other benefits of Acomplia diet pill are smoking cessation, improvement in cardio-metabolic risk factors, and reduces the chances of weight regain as proven by 2 years of clinical trials.
Until the FDA gives approval for Acomplia, the US obese have to be a little patient. |
